Market Research Report
Global Nucleic Acid Isolation and Purification Market: Focus on Product, End User, Region/Country Data and Competitive Landscape - Analysis and Forecast, 2020-2029
|Published by||BIS Research Inc.||Product code||931360|
|Published||Content info||388 Pages
Delivery time: 1-2 business days
|Global Nucleic Acid Isolation and Purification Market: Focus on Product, End User, Region/Country Data and Competitive Landscape - Analysis and Forecast, 2020-2029|
|Published: March 31, 2020||Content info: 388 Pages||
The nucleic acid isolation and purification industry analysis by BIS Research projects the market to grow at a significant CAGR of 5.98% during the forecast period, 2020-2029. The nucleic acid isolation and purification market generated $2,273.9 million revenue in 2020, in terms of value. The nucleic acid isolation and purification market growth has been primarily attributed to the major drivers in this market, such as growing number of genetic tests, increasing demand for reliable next-generation sequencing (NGS) results, rise in the prevalence of infectious diseases, increasing research funding in the field of molecular biology, and increase in awareness and acceptance of personalized medicine on a global level. However, genomic data protection, high cost of automated instruments, and rigid regulatory standards are some of the factors expected to retrain the market growth.
"As molecular diagnostic testing moves into the clinical laboratory environment, products used to collect and process samples will need to be standardized"
Scope of the Market Intelligence on Nucleic Acid Isolation and Purification Market
The nucleic acid isolation and purification research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products and manufacturers. In addition, the study also includes exhaustive information on the drivers, restraints opportunities, perception of the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global nucleic acid isolation and purification market.
The nucleic acid isolation and purification market (on the basis of product type) is segmented into instruments and consumables (kits and reagents).
The kits segment (on the basis of technology) has been classified into magnetic particle technology, silica technology, and other technologies. The other technologies have been broadly bifurcated into anion-exchange technology, lysis, precipitation-based chemistries, organic extraction, fluorescence, and other kits technologies.
Further, the instruments (on the basis of technology) has been classified into automated spin-column based and bead-based. The bead-based technology has been further bifurcated into magnetic bead-based and automated liquid handling.
The nucleic acid isolation and purification market (on the basis of applications) is segmented into PCR, qPCR, NGS, cloning, microarray, blotting techniques, and other applications.
The nucleic acid isolation and purification market (on the basis of end-user) is segmented into academic research institutes, pharmaceutical and biotechnology companies, applied testing, biobanks, contract research organizations, hospital research laboratories, and clinical diagnostic centers.
The nucleic acid isolation and purification market (on the basis of region) is segmented into North America, EMEA, Asia-Pacific, and Latin America.
Key Companies in the Nucleic Acid Isolation and Purification Market
The key manufacturers who have been contributing significantly to the nucleic acid isolation and purification market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F.Hoffmann-La Roche AG, Illumina, Inc., General Electric Company (GE), New England Biolabs, Inc., Promega Corporation, Merck KGaA, Takara Bio Inc., QIAGEN N.N., Thermo Fisher Scientific Inc., and Promega Corporation, among others.